PharmiWeb14m
Phacilitate Awards Katherine High with the 2025 Lifetime Achievement Award at the Advanced Therapies Awards Ceremony in Dallas
Phacilitate, a leading brand that connects advanced therapies industry leaders through inspiring conferences, vibrant communities and market intelligence, today presented Katherine A. High, M.D. with ...
PharmiWeb15m
2.5 Million Grant Awarded to Indiana University School of Medicine, Beckman Coulter Life Sciences to Expand Leukemia and Lymphoma Testing in Africa
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, along with the Indiana University School of Medicine, have been awarded a prestigious grant from the National ...
PharmiWeb17m
OGT delivers superior MRD detection capabilities with new SureSeq Myeloid MRD Panel
OGT announces the North American launch of its new next-generation sequencing (NGS) SureSeq™ Myeloid MRD Panel, which provides a flexible NGS workflow for the detection of ultra-low frequency ...
PharmiWeb18m
OKYO Pharma Receives $1.4 Million in Non-Dilutive Funding
OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...
PharmiWeb1h
KindlyMD(R) Opens New Integrated Behavioral Health Clinic on the Ogden Regional Medical Center Campus
The hospital location positions KindlyMD to expand its core service offerings into Weber County SALT LAKE CITY, UT / ACCESS Newswire / January 22, 2025 / KindlyMD ("KindlyMD" or the "Company") (NASDAQ ...
PharmiWeb1h
New Natural Sleep Aid Innovation Combines Traditional Ingredients With Modern Science
SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / January 22, 2025 / Perfiby, a California-based wellness company, today announced the launch of its innovative Sleep Aid Capsule, combining elderberry ...
PharmiWeb2h
Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR
Positive Phase 1b Data Confirms Overdose Protection for Highest Dosage Form of PF614-MPAR ~ SAN DIEGO, CA / ACCESS Newswire / January 22, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or ...
PharmiWeb2h
Dermata Therapeutics Announces $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules
SAN DIEGO, CA / ACCESS Newswire / January 22, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment ...
PharmiWeb2h
Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million
CHICAGO, IL / ACCESS Newswire / January 22, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in ...
PharmiWeb2h
CBD Life Sciences Inc. (CBDL) Announces Open Market Share Buyback
Company Reports 3.5 billion Share Reduction from the Authorization SCOTTSDALE, AZ / ACCESS Newswire / January 22, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a trailblazer in the CBD and wellness ...
PharmiWeb4h
New study paves way for immunotherapies tailored for childhood cancers
Researchers at Karolinska Institutet and the Astrid Lindgren Children’s Hospital in Sweden have determined how children’s ...
PharmiWeb4h
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2024
Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX (daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under the ...